Comprehensive Solutions For Clinical Development Of Generic Drugs
Source: Syngene International Ltd.
Syngene offers comprehensive solutions for clinical development of generic drugs. Our scientists have the skills and the capability to deliver great science on time and within budget while ensuring the highest levels of data integrity, IP security, and quality.
So far, we have completed ~700 Bioavailability/Bioequivalence (BA/BE) studies for global clients successfully.
Syngene's bioanalytical laboratory for small molecules has been inspected and approved by the US FDA, Brazil's National Health Surveillance Agency (ANVISA), Medicines and Healthcare products Regulatory Agency (MHRA), and the European Medicines Agency (EMA).
access the Datasheet!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.
Subscribe to Outsourced Pharma
X
Subscribe to Outsourced Pharma
This website uses cookies to ensure you get the best experience on our website. Learn more